https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-08484&r=1
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus...
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/...
cdk4 6 inhibitor
https://www.breastcancer.org/research-news/cdk46-inhibitor-plus-ai-helps-despite-age
CDK4/6 Inhibitor and Aromatase Inhibitor Effective At Any Age
CDK4/6 inhibitors combined with an aromatase inhibitor to treat metastatic, hormone receptor-positive, HER2-negative breast cancer is effective for women at...
cdk4 6 inhibitoraromataseeffectiveage